Jacobio Pharmaceuticals Group Co., Ltd.
Research Jacobio Pharmaceuticals Group Co., Ltd. (77V) on Bullrun: market cap EUR 410.64M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker77V
- ExchangeF
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 410.64M
- Financial periodFY2025
- RevenueCNY 53.53M
- Revenue growth-65.6%
- Net income-CNY 145.98M
- Free cash flow-CNY 212.71M
- Gross margin98.9%
Valuation Snapshot
latest market cap is EUR 410.64M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 53.53M | -CNY 145.98M | -CNY 212.71M | 98.9% | -0.19 | CNY 943.65M | CNY 165.17M | CNY 770.63M |
| FY2024 | CNY 155.71M | -CNY 155.71M | -CNY 86.21M | 100.0% | -0.2 | CNY 1.17B | CNY 152.08M | CNY 923.18M |
| FY2023 | CNY 63.52M | -CNY 359.12M | -CNY 402.86M | 5.0% | -0.46 | CNY 1.14B | CNY 209.91M | CNY 1.07B |
| FY2022 | CNY 95.75M | -CNY 371.86M | -CNY 308.92M | 13.2% | -0.49 | CNY 1.28B | CNY 147.79M | CNY 1.28B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 410.64M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Jacobio Pharmaceuticals Group Co., Ltd.
Jacobio Pharmaceuticals Group Co., Ltd., an investment holding company, engages in the in-house discovery and development of oncology therapies in the People's Republic of China. The company develops sitneprotafib (JAB-3312), an oral allosteric SHP2 inhibitor that is in a Phase III trial for non-small cell lung cancer (NSCLC); glecirasib (JAB-21822), a KRAS G12C allosteric inhibitor in Phase II trials for NSCLC, multi-tumor basket, and colorectal cancer;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Jacobio Pharmaceuticals Group Co., Ltd.'s market cap?
Jacobio Pharmaceuticals Group Co., Ltd.'s market capitalization is EUR 410.64M.
What does Jacobio Pharmaceuticals Group Co., Ltd. do?
Jacobio Pharmaceuticals Group Co., Ltd., an investment holding company, engages in the in-house discovery and development of oncology therapies in the People's Republic of China.